Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Feb 15, 2019; 11(2): 102-116
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.102
Figure 1
Figure 1 Pancreatic Ductal Adenocarcinoma patient selection flow diagram: A total of 408 patients were screened; 400 patients were eligible. Six patients were excluded due to having diagnoses of other malignancies other than Pancreatic Ductal Adenocarcinoma; the remaining 2 patients excluded did not have a confirmed malignancy and were therefore excluded. n: Number of patients.
Figure 2
Figure 2 Flow diagram of patients’ suitability for referral using European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer criteria, along with referral outcome. DNA: Did not attend.